| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 6.07e-11 | 46 | 30 | 6 | GO:0030020 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 9.94e-09 | 188 | 30 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.31e-05 | 4 | 30 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.62e-05 | 33 | 30 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 3.26e-05 | 6 | 30 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | structural molecule activity | 3.71e-05 | 891 | 30 | 8 | GO:0005198 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 3.29e-04 | 18 | 30 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 9.88e-04 | 31 | 30 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.19e-03 | 140 | 30 | 3 | GO:0099094 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 2.98e-03 | 193 | 30 | 3 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 3.16e-03 | 197 | 30 | 3 | GO:0022834 | |
| GeneOntologyMolecularFunction | lyase activity | 3.88e-03 | 212 | 30 | 3 | GO:0016829 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 3.90e-03 | 62 | 30 | 2 | GO:0003678 | |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 5.45e-07 | 12 | 29 | 3 | GO:0038063 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 2.01e-06 | 18 | 29 | 3 | GO:0038065 | |
| GeneOntologyBiologicalProcess | oocyte growth | 1.14e-05 | 4 | 29 | 2 | GO:0001555 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 1.19e-05 | 377 | 29 | 6 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 1.21e-05 | 378 | 29 | 6 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 1.23e-05 | 379 | 29 | 6 | GO:0045229 | |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell signaling | 8.53e-05 | 10 | 29 | 2 | GO:0086018 | |
| GeneOntologyBiologicalProcess | SA node cell action potential | 8.53e-05 | 10 | 29 | 2 | GO:0086015 | |
| GeneOntologyBiologicalProcess | glomerular basement membrane development | 8.53e-05 | 10 | 29 | 2 | GO:0032836 | |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell communication | 1.04e-04 | 11 | 29 | 2 | GO:0086070 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 1.04e-04 | 11 | 29 | 2 | GO:0071313 | |
| GeneOntologyBiologicalProcess | circulatory system development | 1.08e-04 | 1442 | 29 | 9 | GO:0072359 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 1.72e-04 | 14 | 29 | 2 | GO:0071415 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 2.69e-04 | 1269 | 29 | 8 | GO:0009887 | |
| GeneOntologyBiologicalProcess | response to caffeine | 3.94e-04 | 21 | 29 | 2 | GO:0031000 | |
| GeneOntologyBiologicalProcess | notochord development | 5.17e-04 | 24 | 29 | 2 | GO:0030903 | |
| GeneOntologyBiologicalProcess | embryo development | 6.23e-04 | 1437 | 29 | 8 | GO:0009790 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell action potential | 8.10e-04 | 30 | 29 | 2 | GO:0098901 | |
| GeneOntologyBiologicalProcess | cell-cell signaling involved in cardiac conduction | 1.04e-03 | 34 | 29 | 2 | GO:0086019 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 1.23e-03 | 37 | 29 | 2 | GO:0014808 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 1.37e-03 | 39 | 29 | 2 | GO:1903514 | |
| GeneOntologyBiologicalProcess | cellular response to alkaloid | 1.44e-03 | 40 | 29 | 2 | GO:0071312 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 2.74e-13 | 21 | 30 | 6 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 5.16e-11 | 6 | 30 | 4 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 2.40e-10 | 8 | 30 | 4 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 2.40e-10 | 8 | 30 | 4 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 2.40e-10 | 8 | 30 | 4 | GO:0098645 | |
| GeneOntologyCellularComponent | collagen trimer | 2.56e-09 | 88 | 30 | 6 | GO:0005581 | |
| GeneOntologyCellularComponent | basement membrane | 7.91e-07 | 122 | 30 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 6.60e-06 | 332 | 30 | 6 | GO:0005788 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 7.94e-06 | 530 | 30 | 7 | GO:0062023 | |
| GeneOntologyCellularComponent | extracellular matrix | 3.15e-05 | 656 | 30 | 7 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 3.21e-05 | 658 | 30 | 7 | GO:0030312 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 8.90e-05 | 10 | 30 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 1.30e-04 | 12 | 30 | 2 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 1.30e-04 | 12 | 30 | 2 | GO:0098643 | |
| GeneOntologyCellularComponent | supramolecular polymer | 2.01e-04 | 1187 | 30 | 8 | GO:0099081 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 1.90e-03 | 45 | 30 | 2 | GO:0033017 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 1.98e-03 | 46 | 30 | 2 | GO:0005790 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 2.32e-03 | 185 | 30 | 3 | GO:0009898 | |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 2.92e-03 | 56 | 30 | 2 | GO:0031234 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 4.29e-03 | 230 | 30 | 3 | GO:0098562 | |
| GeneOntologyCellularComponent | cation channel complex | 4.55e-03 | 235 | 30 | 3 | GO:0034703 | |
| GeneOntologyCellularComponent | calcium channel complex | 4.91e-03 | 73 | 30 | 2 | GO:0034704 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 7.06e-03 | 88 | 30 | 2 | GO:0016529 | |
| HumanPheno | Lenticonus | 4.38e-06 | 10 | 18 | 3 | HP:0001142 | |
| HumanPheno | Abnormality of lens shape | 2.93e-05 | 18 | 18 | 3 | HP:0011526 | |
| HumanPheno | Glomerular basement membrane lamellation | 3.53e-05 | 3 | 18 | 2 | HP:0030034 | |
| HumanPheno | Anterior lenticonus | 3.53e-05 | 3 | 18 | 2 | HP:0011501 | |
| HumanPheno | Thin glomerular basement membrane | 3.53e-05 | 3 | 18 | 2 | HP:0012577 | |
| MousePheno | kidney hemorrhage | 2.05e-06 | 14 | 26 | 3 | MP:0000533 | |
| MousePheno | glomerular crescent | 5.43e-06 | 19 | 26 | 3 | MP:0011506 | |
| MousePheno | abnormal fetal growth/weight/body size | 1.86e-05 | 312 | 26 | 6 | MP:0004197 | |
| MousePheno | renal cast | 3.29e-05 | 34 | 26 | 3 | MP:0011402 | |
| MousePheno | podocyte foot process effacement | 4.61e-05 | 38 | 26 | 3 | MP:0008140 | |
| MousePheno | retrognathia | 6.95e-05 | 7 | 26 | 2 | MP:0004282 | |
| MousePheno | podocyte hypertrophy | 6.95e-05 | 7 | 26 | 2 | MP:0011871 | |
| MousePheno | podocyte microvillus transformation | 6.95e-05 | 7 | 26 | 2 | MP:0011868 | |
| MousePheno | abnormal renal glomerulus basement membrane morphology | 7.19e-05 | 44 | 26 | 3 | MP:0011348 | |
| MousePheno | kidney failure | 8.22e-05 | 46 | 26 | 3 | MP:0003606 | |
| MousePheno | expanded mesangial matrix | 8.22e-05 | 46 | 26 | 3 | MP:0011353 | |
| MousePheno | abnormal mesangial matrix morphology | 1.12e-04 | 51 | 26 | 3 | MP:0011338 | |
| MousePheno | abnormal podocyte foot process morphology | 1.41e-04 | 55 | 26 | 3 | MP:0008059 | |
| MousePheno | albuminuria | 2.11e-04 | 63 | 26 | 3 | MP:0002871 | |
| MousePheno | glomerulosclerosis | 2.64e-04 | 68 | 26 | 3 | MP:0005264 | |
| MousePheno | abnormal podocyte morphology | 2.88e-04 | 70 | 26 | 3 | MP:0005326 | |
| MousePheno | abnormal glomerular capsule visceral layer morphology | 2.88e-04 | 70 | 26 | 3 | MP:0011497 | |
| MousePheno | aorta stenosis | 4.45e-04 | 17 | 26 | 2 | MP:0010463 | |
| MousePheno | abnormal glomerular mesangium morphology | 4.76e-04 | 83 | 26 | 3 | MP:0011339 | |
| MousePheno | chondrodystrophy | 5.00e-04 | 18 | 26 | 2 | MP:0002657 | |
| MousePheno | domed cranium | 5.10e-04 | 85 | 26 | 3 | MP:0000440 | |
| MousePheno | craniofacial phenotype | 5.48e-04 | 1372 | 26 | 9 | MP:0005382 | |
| MousePheno | abnormal craniofacial morphology | 5.48e-04 | 1372 | 26 | 9 | MP:0000428 | |
| MousePheno | hematuria | 5.58e-04 | 19 | 26 | 2 | MP:0005161 | |
| MousePheno | abnormal blood urea nitrogen level | 6.60e-04 | 389 | 26 | 5 | MP:0005265 | |
| MousePheno | abnormal blood circulation | 6.86e-04 | 845 | 26 | 7 | MP:0002128 | |
| MousePheno | abnormal head morphology | 7.00e-04 | 1120 | 26 | 8 | MP:0000432 | |
| MousePheno | abnormal renal tubule morphology | 7.64e-04 | 227 | 26 | 4 | MP:0002703 | |
| MousePheno | abnormal sarcoplasmic reticulum morphology | 8.22e-04 | 23 | 26 | 2 | MP:0004088 | |
| MousePheno | abnormal renal glomerular capsule morphology | 9.97e-04 | 107 | 26 | 3 | MP:0002828 | |
| MousePheno | increased renal glomerulus basement membrane thickness | 1.13e-03 | 27 | 26 | 2 | MP:0011409 | |
| MousePheno | hemorrhage | 1.14e-03 | 664 | 26 | 6 | MP:0001914 | |
| MousePheno | abnormal artery morphology | 1.15e-03 | 440 | 26 | 5 | MP:0002191 | |
| Domain | C4 | 8.09e-11 | 6 | 30 | 4 | SM00111 | |
| Domain | - | 8.09e-11 | 6 | 30 | 4 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 8.09e-11 | 6 | 30 | 4 | IPR001442 | |
| Domain | NC1_IV | 8.09e-11 | 6 | 30 | 4 | PS51403 | |
| Domain | C4 | 8.09e-11 | 6 | 30 | 4 | PF01413 | |
| Domain | Collagen | 4.04e-09 | 85 | 30 | 6 | PF01391 | |
| Domain | Collagen | 4.04e-09 | 85 | 30 | 6 | IPR008160 | |
| Domain | RyR | 7.48e-06 | 3 | 30 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 7.48e-06 | 3 | 30 | 2 | IPR003032 | |
| Domain | RR_TM4-6 | 7.48e-06 | 3 | 30 | 2 | PF06459 | |
| Domain | Ryanrecept_TM4-6 | 7.48e-06 | 3 | 30 | 2 | IPR009460 | |
| Domain | Ryan_recept | 7.48e-06 | 3 | 30 | 2 | IPR013333 | |
| Domain | CTDL_fold | 2.49e-05 | 107 | 30 | 4 | IPR016187 | |
| Domain | RIH_assoc | 3.73e-05 | 6 | 30 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 3.73e-05 | 6 | 30 | 2 | IPR013662 | |
| Domain | RYDR_ITPR | 3.73e-05 | 6 | 30 | 2 | PF01365 | |
| Domain | RIH_dom | 3.73e-05 | 6 | 30 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 3.73e-05 | 6 | 30 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 3.73e-05 | 6 | 30 | 2 | IPR015925 | |
| Domain | Ins145_P3_rec | 3.73e-05 | 6 | 30 | 2 | PF08709 | |
| Domain | - | 3.73e-05 | 6 | 30 | 2 | 1.25.10.30 | |
| Domain | MIR | 1.11e-04 | 10 | 30 | 2 | PS50919 | |
| Domain | MIR | 1.11e-04 | 10 | 30 | 2 | PF02815 | |
| Domain | MIR | 1.11e-04 | 10 | 30 | 2 | SM00472 | |
| Domain | MIR_motif | 1.11e-04 | 10 | 30 | 2 | IPR016093 | |
| Domain | NC1_FIB | 1.36e-04 | 11 | 30 | 2 | PS51461 | |
| Domain | Fib_collagen_C | 1.36e-04 | 11 | 30 | 2 | IPR000885 | |
| Domain | Fib_collagen_C | 1.36e-04 | 11 | 30 | 2 | PD002078 | |
| Domain | COLFI | 1.36e-04 | 11 | 30 | 2 | SM00038 | |
| Domain | COLFI | 1.36e-04 | 11 | 30 | 2 | PF01410 | |
| Domain | Ion_trans_dom | 7.97e-04 | 114 | 30 | 3 | IPR005821 | |
| Domain | Ion_trans | 7.97e-04 | 114 | 30 | 3 | PF00520 | |
| Domain | EF-hand_8 | 1.36e-03 | 34 | 30 | 2 | PF13833 | |
| Domain | ConA-like_dom | 5.11e-03 | 219 | 30 | 3 | IPR013320 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.83e-10 | 44 | 27 | 6 | M27812 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.41e-09 | 61 | 27 | 6 | M27103 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 2.22e-09 | 10 | 27 | 4 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 2.22e-09 | 10 | 27 | 4 | MM1560 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 2.51e-09 | 67 | 27 | 6 | M26999 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.39e-09 | 32 | 27 | 5 | MM14924 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 3.49e-09 | 11 | 27 | 4 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 5.23e-09 | 12 | 27 | 4 | MM1526 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 7.54e-09 | 13 | 27 | 4 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 7.54e-09 | 13 | 27 | 4 | M12950 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.05e-08 | 14 | 27 | 4 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.05e-08 | 14 | 27 | 4 | M6487 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.25e-08 | 41 | 27 | 5 | MM15538 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.44e-08 | 15 | 27 | 4 | M27161 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.44e-08 | 15 | 27 | 4 | MM14922 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.52e-08 | 90 | 27 | 6 | M631 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 3.21e-08 | 18 | 27 | 4 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 3.21e-08 | 18 | 27 | 4 | MM14882 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 3.48e-08 | 50 | 27 | 5 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 4.69e-08 | 53 | 27 | 5 | MM14566 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 5.06e-08 | 20 | 27 | 4 | M15394 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 5.06e-08 | 20 | 27 | 4 | MM15061 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 8.13e-08 | 59 | 27 | 5 | M27218 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 9.22e-08 | 23 | 27 | 4 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 9.22e-08 | 23 | 27 | 4 | MM1427 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 9.63e-08 | 61 | 27 | 5 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.23e-07 | 64 | 27 | 5 | M26953 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.83e-07 | 30 | 27 | 4 | M27216 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.93e-07 | 76 | 27 | 5 | MM14573 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.93e-07 | 76 | 27 | 5 | M27219 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.93e-07 | 76 | 27 | 5 | MM14867 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 5.15e-07 | 85 | 27 | 5 | M16441 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 7.53e-07 | 38 | 27 | 4 | MM14969 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.14e-06 | 300 | 27 | 7 | M610 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.14e-06 | 42 | 27 | 4 | M7169 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.65e-06 | 46 | 27 | 4 | M198 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.22e-06 | 114 | 27 | 5 | MM14571 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 3.93e-06 | 57 | 27 | 4 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 4.22e-06 | 58 | 27 | 4 | M2049 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 5.88e-06 | 63 | 27 | 4 | M11187 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 6.09e-06 | 140 | 27 | 5 | M587 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 7.09e-06 | 66 | 27 | 4 | M18 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 7.60e-06 | 258 | 27 | 6 | MM14572 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 1.12e-05 | 74 | 27 | 4 | M160 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.85e-05 | 84 | 27 | 4 | M7098 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 3.14e-05 | 96 | 27 | 4 | M39834 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 7.35e-05 | 43 | 27 | 3 | M53 | |
| Pathway | WP_NEPHROTIC_SYNDROME | 8.43e-05 | 45 | 27 | 3 | M39864 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.92e-04 | 11 | 27 | 2 | M47958 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 2.34e-04 | 161 | 27 | 4 | M39770 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 2.72e-04 | 13 | 27 | 2 | M39589 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 3.42e-04 | 72 | 27 | 3 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 3.56e-04 | 73 | 27 | 3 | MM15906 | |
| Pathway | WP_PI3KAKT_SIGNALING | 4.08e-04 | 339 | 27 | 5 | M39736 | |
| Pathway | WP_FOCAL_ADHESION | 4.14e-04 | 187 | 27 | 4 | MM15913 | |
| Pathway | KEGG_FOCAL_ADHESION | 5.24e-04 | 199 | 27 | 4 | M7253 | |
| Pathway | WP_FOCAL_ADHESION | 5.24e-04 | 199 | 27 | 4 | M39402 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 5.38e-04 | 84 | 27 | 3 | M3228 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 5.92e-04 | 19 | 27 | 2 | M47760 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.44e-03 | 261 | 27 | 4 | MM15676 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.49e-03 | 30 | 27 | 2 | M27772 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 2.46e-03 | 302 | 27 | 4 | M39719 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.77e-03 | 41 | 27 | 2 | M27778 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 3.04e-03 | 532 | 27 | 5 | M27870 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 3.24e-03 | 326 | 27 | 4 | MM15917 | |
| Pathway | WP_15Q25_COPY_NUMBER_VARIATION | 3.47e-03 | 46 | 27 | 2 | M48105 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 4.75e-03 | 54 | 27 | 2 | MM15202 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 4.75e-03 | 54 | 27 | 2 | M27460 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 7.79e-03 | 418 | 27 | 4 | MM15587 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 9.23e-03 | 439 | 27 | 4 | M42563 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 9.94e-03 | 79 | 27 | 2 | M27643 | |
| Pubmed | 1.88e-14 | 8 | 30 | 5 | 10382266 | ||
| Pubmed | 1.88e-14 | 8 | 30 | 5 | 3997552 | ||
| Pubmed | 2.25e-12 | 5 | 30 | 4 | 9409248 | ||
| Pubmed | 3.88e-12 | 19 | 30 | 5 | 15689378 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 6.74e-12 | 6 | 30 | 4 | 10534397 | |
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 6.74e-12 | 6 | 30 | 4 | 9506531 | |
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 6.74e-12 | 6 | 30 | 4 | 9673377 | |
| Pubmed | 6.74e-12 | 6 | 30 | 4 | 2426947 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 6.74e-12 | 6 | 30 | 4 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 6.74e-12 | 6 | 30 | 4 | 6811420 | |
| Pubmed | 6.74e-12 | 6 | 30 | 4 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 6.74e-12 | 6 | 30 | 4 | 19275937 | |
| Pubmed | 6.74e-12 | 6 | 30 | 4 | 6988303 | ||
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 6.74e-12 | 6 | 30 | 4 | 6389236 | |
| Pubmed | 6.74e-12 | 6 | 30 | 4 | 12225806 | ||
| Pubmed | 1.57e-11 | 7 | 30 | 4 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 1.57e-11 | 7 | 30 | 4 | 8006028 | |
| Pubmed | 1.57e-11 | 7 | 30 | 4 | 10416788 | ||
| Pubmed | 1.57e-11 | 7 | 30 | 4 | 1724753 | ||
| Pubmed | 3.14e-11 | 8 | 30 | 4 | 29422532 | ||
| Pubmed | 5.65e-11 | 9 | 30 | 4 | 9878537 | ||
| Pubmed | 5.65e-11 | 9 | 30 | 4 | 12101409 | ||
| Pubmed | 9.41e-11 | 10 | 30 | 4 | 9136074 | ||
| Pubmed | 1.48e-10 | 11 | 30 | 4 | 14998921 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 1.48e-10 | 11 | 30 | 4 | 7500359 | |
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 2.22e-10 | 12 | 30 | 4 | 15837576 | |
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 2.22e-10 | 12 | 30 | 4 | 12180907 | |
| Pubmed | 2.22e-10 | 12 | 30 | 4 | 16024816 | ||
| Pubmed | 4.47e-10 | 14 | 30 | 4 | 12878203 | ||
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 3089234 | ||
| Pubmed | 8.12e-10 | 16 | 30 | 4 | 15878328 | ||
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 2.10e-09 | 62 | 30 | 5 | 28344315 | |
| Pubmed | Nature and the multiple functions of the 67-kD elastin-/laminin binding protein. | 2.32e-09 | 4 | 30 | 3 | 7827955 | |
| Pubmed | 6.63e-09 | 26 | 30 | 4 | 24742657 | ||
| Pubmed | 8.00e-09 | 175 | 30 | 6 | 28071719 | ||
| Pubmed | 1.16e-08 | 6 | 30 | 3 | 7495302 | ||
| Pubmed | 1.39e-08 | 31 | 30 | 4 | 22925884 | ||
| Pubmed | 2.02e-08 | 7 | 30 | 3 | 10639489 | ||
| Pubmed | 2.02e-08 | 7 | 30 | 3 | 7521231 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 2.02e-08 | 7 | 30 | 3 | 10716744 | |
| Pubmed | Large-scale identification of genes implicated in kidney glomerulus development and function. | 2.05e-08 | 34 | 30 | 4 | 16498405 | |
| Pubmed | 3.23e-08 | 8 | 30 | 3 | 11683410 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 3.23e-08 | 8 | 30 | 3 | 10970885 | |
| Pubmed | 3.23e-08 | 8 | 30 | 3 | 1377218 | ||
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 3.23e-08 | 8 | 30 | 3 | 11867580 | |
| Pubmed | 4.02e-08 | 40 | 30 | 4 | 27068110 | ||
| Pubmed | 4.85e-08 | 9 | 30 | 3 | 8562707 | ||
| Pubmed | 4.85e-08 | 9 | 30 | 3 | 10880400 | ||
| Pubmed | 4.85e-08 | 9 | 30 | 3 | 8995276 | ||
| Pubmed | 6.92e-08 | 10 | 30 | 3 | 9415455 | ||
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 9.51e-08 | 11 | 30 | 3 | 9731539 | |
| Pubmed | 1.27e-07 | 12 | 30 | 3 | 8918877 | ||
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 1.65e-07 | 13 | 30 | 3 | 9833687 | |
| Pubmed | 2.01e-07 | 153 | 30 | 5 | 25037231 | ||
| Pubmed | 2.09e-07 | 14 | 30 | 3 | 19858219 | ||
| Pubmed | 2.62e-07 | 15 | 30 | 3 | 10625553 | ||
| Pubmed | 2.62e-07 | 15 | 30 | 3 | 9264260 | ||
| Pubmed | Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. | 2.62e-07 | 15 | 30 | 3 | 10706142 | |
| Pubmed | 3.91e-07 | 17 | 30 | 3 | 18082680 | ||
| Pubmed | 4.68e-07 | 18 | 30 | 3 | 9160753 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 6.46e-07 | 79 | 30 | 4 | 18757743 | |
| Pubmed | COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome. | 7.19e-07 | 2 | 30 | 2 | 24052634 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 19357112 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 12768082 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 30542613 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 25229338 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 17942953 | ||
| Pubmed | Polymorphisms in COL4A3 and COL4A4 genes associated with keratoconus. | 7.19e-07 | 2 | 30 | 2 | 20029656 | |
| Pubmed | Mutation analysis of COL4A3 and COL4A4 genes in a Chinese autosomal-dominant Alport syndrome family. | 7.19e-07 | 2 | 30 | 2 | 28674241 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 15280431 | ||
| Pubmed | Expression of the ryanodine receptor isoforms in immune cells. | 7.19e-07 | 2 | 30 | 2 | 11673493 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 11673462 | ||
| Pubmed | Persistent familial hematuria in children and the locus for thin basement membrane nephropathy. | 7.19e-07 | 2 | 30 | 2 | 16235097 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 9537506 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 25381091 | ||
| Pubmed | Collagen type IV (alpha3-alpha4) nephropathy: from isolated haematuria to renal failure. | 7.19e-07 | 2 | 30 | 2 | 15280517 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 7987396 | ||
| Pubmed | Heterozygous COL4A3/COL4A4 mutations: the hidden part of the iceberg? | 7.19e-07 | 2 | 30 | 2 | 35090027 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 15880327 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 29742505 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 33305316 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 38214412 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 17259277 | ||
| Pubmed | Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain. | 7.19e-07 | 2 | 30 | 2 | 25370123 | |
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 7.19e-07 | 2 | 30 | 2 | 15033925 | |
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 7.19e-07 | 2 | 30 | 2 | 14722100 | |
| Pubmed | Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases. | 7.19e-07 | 2 | 30 | 2 | 17216251 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 26138234 | ||
| Pubmed | Structural and functional interactions within ryanodine receptor. | 7.19e-07 | 2 | 30 | 2 | 26009179 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 35369551 | ||
| Pubmed | Presumed COL4A3/COL4A4 Missense/Synonymous Variants Induce Aberrant Splicing. | 7.19e-07 | 2 | 30 | 2 | 35386907 | |
| Pubmed | COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome. | 7.19e-07 | 2 | 30 | 2 | 12028435 | |
| Pubmed | Polymorphism analysis of COL4A3 and COL4A4 genes in Greek patients with keratoconus. | 7.19e-07 | 2 | 30 | 2 | 25083577 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 20847057 | ||
| Pubmed | Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels. | 7.19e-07 | 2 | 30 | 2 | 18618700 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 32899693 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 25307543 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 18661361 | ||
| Pubmed | Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome. | 7.19e-07 | 2 | 30 | 2 | 27281700 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 34088380 | ||
| Interaction | HABP2 interactions | 1.20e-08 | 18 | 30 | 4 | int:HABP2 | |
| Interaction | OSM interactions | 1.90e-08 | 20 | 30 | 4 | int:OSM | |
| Interaction | MMP9 interactions | 4.66e-08 | 67 | 30 | 5 | int:MMP9 | |
| Interaction | TGFBI interactions | 4.94e-08 | 25 | 30 | 4 | int:TGFBI | |
| Interaction | CD93 interactions | 5.70e-07 | 45 | 30 | 4 | int:CD93 | |
| Interaction | LAIR2 interactions | 8.07e-07 | 49 | 30 | 4 | int:LAIR2 | |
| Interaction | SERPINE2 interactions | 1.39e-06 | 56 | 30 | 4 | int:SERPINE2 | |
| Interaction | FN1 interactions | 2.55e-06 | 848 | 30 | 9 | int:FN1 | |
| Interaction | FBLN2 interactions | 2.70e-06 | 66 | 30 | 4 | int:FBLN2 | |
| Interaction | ANTXR2 interactions | 1.06e-05 | 29 | 30 | 3 | int:ANTXR2 | |
| Interaction | MATN2 interactions | 2.29e-05 | 113 | 30 | 4 | int:MATN2 | |
| Interaction | SOX2 interactions | 2.41e-05 | 1422 | 30 | 10 | int:SOX2 | |
| Interaction | COL8A2 interactions | 3.29e-05 | 42 | 30 | 3 | int:COL8A2 | |
| Interaction | DCN interactions | 3.53e-05 | 43 | 30 | 3 | int:DCN | |
| Interaction | C1QTNF1 interactions | 4.62e-05 | 47 | 30 | 3 | int:C1QTNF1 | |
| Interaction | SAA1 interactions | 7.01e-05 | 54 | 30 | 3 | int:SAA1 | |
| Interaction | P4HA1 interactions | 7.19e-05 | 298 | 30 | 5 | int:P4HA1 | |
| Interaction | COL9A1 interactions | 1.65e-04 | 13 | 30 | 2 | int:COL9A1 | |
| Interaction | KCNA3 interactions | 2.34e-04 | 871 | 30 | 7 | int:KCNA3 | |
| Interaction | AKAP6 interactions | 2.87e-04 | 17 | 30 | 2 | int:AKAP6 | |
| Interaction | FKBP9 interactions | 2.90e-04 | 87 | 30 | 3 | int:FKBP9 | |
| Interaction | MMP2 interactions | 2.90e-04 | 87 | 30 | 3 | int:MMP2 | |
| Interaction | ERG interactions | 3.19e-04 | 223 | 30 | 4 | int:ERG | |
| Cytoband | Xq22 | 9.46e-05 | 22 | 30 | 2 | Xq22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q36 | 1.42e-03 | 85 | 30 | 2 | chr2q36 | |
| GeneFamily | Collagens | 1.02e-11 | 46 | 21 | 6 | 490 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 3.85e-06 | 3 | 21 | 2 | 287 | |
| Coexpression | NABA_COLLAGENS | 7.81e-12 | 43 | 30 | 6 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 9.04e-12 | 44 | 30 | 6 | M3005 | |
| Coexpression | NABA_CORE_MATRISOME | 1.89e-08 | 270 | 30 | 7 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 2.15e-08 | 275 | 30 | 7 | M5884 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.24e-07 | 40 | 30 | 4 | M5887 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 2.36e-06 | 23 | 30 | 3 | M48001 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN | 3.57e-05 | 164 | 30 | 4 | M13108 | |
| Coexpression | PEREZ_TP53_TARGETS | 4.50e-05 | 1201 | 30 | 8 | M4391 | |
| Coexpression | GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP | 7.14e-05 | 196 | 30 | 4 | M8683 | |
| Coexpression | GSE27786_BCELL_VS_MONO_MAC_DN | 7.72e-05 | 200 | 30 | 4 | M4818 | |
| Coexpression | GSE557_WT_VS_CIITA_KO_DC_DN | 7.72e-05 | 200 | 30 | 4 | M6008 | |
| Coexpression | GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP | 7.72e-05 | 200 | 30 | 4 | M7898 | |
| Coexpression | HALLMARK_KRAS_SIGNALING_DN | 7.72e-05 | 200 | 30 | 4 | M5956 | |
| Coexpression | NABA_MATRISOME | 1.14e-04 | 1008 | 30 | 7 | MM17056 | |
| Coexpression | BAELDE_DIABETIC_NEPHROPATHY_DN | 1.27e-04 | 437 | 30 | 5 | M4665 | |
| Coexpression | NABA_MATRISOME | 1.27e-04 | 1026 | 30 | 7 | M5889 | |
| Coexpression | KANG_AR_TARGETS_UP | 1.70e-04 | 17 | 30 | 2 | M2223 | |
| Coexpression | KANG_AR_TARGETS_UP | 1.70e-04 | 17 | 30 | 2 | MM1297 | |
| Coexpression | RIZKI_TUMOR_INVASIVENESS_3D_DN | 2.18e-04 | 262 | 30 | 4 | M11472 | |
| Coexpression | SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP | 2.88e-04 | 22 | 30 | 2 | M5840 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | 3.57e-04 | 854 | 30 | 6 | M1533 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGM | 3.98e-04 | 307 | 30 | 4 | M39058 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | 4.40e-04 | 888 | 30 | 6 | MM1018 | |
| Coexpression | CTIP_DN.V1_DN | 4.79e-04 | 134 | 30 | 3 | M2751 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2C | 4.93e-04 | 325 | 30 | 4 | M39053 | |
| Coexpression | HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN | 5.40e-04 | 30 | 30 | 2 | M743 | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 4.13e-06 | 162 | 30 | 4 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 5.47e-06 | 174 | 30 | 4 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.83e-06 | 184 | 30 | 4 | ca940a4f4970285ed284d5517d142abab0682044 | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.76e-06 | 196 | 30 | 4 | cd507ee2baf4f52d6498811b3510d3164b56311f | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.30e-06 | 199 | 30 | 4 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.30e-06 | 199 | 30 | 4 | 2e7f517c0444b4f29ff11c26ab32e9cc0f7e99ef | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.30e-06 | 199 | 30 | 4 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.31e-05 | 121 | 30 | 3 | 5035e071033cb76a7fc0128716755b14821e8f05 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.31e-05 | 121 | 30 | 3 | c96115bd33455296378a257583b49442d00b39ca | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-04 | 146 | 30 | 3 | 669001b772b6d6109a09727619ed5829122b48db | |
| ToppCell | AT1-AT2_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.52e-04 | 155 | 30 | 3 | 010e45ef4b505bf419ea41e4d1619521d1c78319 | |
| ToppCell | severe_COVID-19-cDC|World / disease group, cell group and cell class (v2) | 1.55e-04 | 156 | 30 | 3 | 0a7e18ed8e13261c405eb6b9a183e99d8e1aac37 | |
| ToppCell | severe_COVID-19-cDC|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.58e-04 | 157 | 30 | 3 | ec1978e07e2214048d015d8bb793c1d9991f6e37 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.61e-04 | 158 | 30 | 3 | 8d64c0c9de910a3f4658778642d183c8b9b6f6a2 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.67e-04 | 160 | 30 | 3 | 58ed3a074932ccc951e07868dfdc61b99ae1cc2b | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-04 | 161 | 30 | 3 | 1e17a993126e1f2a25ee7dfbb95a74ccb2a26791 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.70e-04 | 161 | 30 | 3 | 63f0b97c741b610c450f65fa5764d712bfe09ce8 | |
| ToppCell | PND01-03-samps|World / Age Group, Lineage, Cell class and subclass | 1.70e-04 | 161 | 30 | 3 | 1973b112d8d67aacc02751797d0148e7b53bfa66 | |
| ToppCell | AT1_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.73e-04 | 162 | 30 | 3 | ae2ba4f21f6f6c512006fa531d670b88be7c04c9 | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial-AT1|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.83e-04 | 165 | 30 | 3 | b9b6b7b8cd65ba6948a5dd8b715cc7092e0be637 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.86e-04 | 166 | 30 | 3 | 37794a84601a2a949d579663d4a4bb8bc8fb5923 | |
| ToppCell | CV-Mild-3|Mild / Virus stimulation, Condition and Cluster | 1.86e-04 | 166 | 30 | 3 | 5599f90fc0e15a3670b03187085eba91228390a2 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.86e-04 | 166 | 30 | 3 | 81c546c6d847e49e662b81e71992ca0f7a99e890 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 1.96e-04 | 169 | 30 | 3 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.00e-04 | 170 | 30 | 3 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 2.00e-04 | 170 | 30 | 3 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.00e-04 | 170 | 30 | 3 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 171 | 30 | 3 | 355a27ea88410a84210f7e4298c7c4f90cf2f8a9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.03e-04 | 171 | 30 | 3 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | AT1-AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 2.03e-04 | 171 | 30 | 3 | 0b9912f07393aca889db72b40da08e0bc9bc1e8c | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 2.07e-04 | 172 | 30 | 3 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.07e-04 | 172 | 30 | 3 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-Cycling_Dendritic|Lung / Manually curated celltypes from each tissue | 2.10e-04 | 173 | 30 | 3 | 62e0c18cfed9645e34a9d7029c94a8554f773714 | |
| ToppCell | AT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.10e-04 | 173 | 30 | 3 | 3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e | |
| ToppCell | mild_COVID-19_(asymptomatic)-cDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.10e-04 | 173 | 30 | 3 | 71dc0051c87b84e3cf13cde8858166f2a474b5dc | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-04 | 174 | 30 | 3 | 9d5dcd46cf346c381dea68ada6665f7fb68114a3 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-04 | 174 | 30 | 3 | 53cec5c666c45278a71c21dd9c62a052a97e0fdf | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 2.14e-04 | 174 | 30 | 3 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.17e-04 | 175 | 30 | 3 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | AT1-AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.17e-04 | 175 | 30 | 3 | bdd85ba280648a0283c1984662a34c7b840f64dd | |
| ToppCell | IIF-Lymphocyte-B-B_intermediate|IIF / Disease, Lineage and Cell Type | 2.17e-04 | 175 | 30 | 3 | 327f8ee3669c3fc5ba50abc3b4f3e068637fd8d8 | |
| ToppCell | AT1-AT2_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.17e-04 | 175 | 30 | 3 | 9a95ab5c361ebaa8747983c5a0d69025682a19ad | |
| ToppCell | AT1_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 2.21e-04 | 176 | 30 | 3 | 4a30bb771297b30926fb98e2b5ec0dbdc46feac7 | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.21e-04 | 176 | 30 | 3 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | AT1_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 2.25e-04 | 177 | 30 | 3 | 3128b8d04687acee1ac4190b2569d6328b98eaf3 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.29e-04 | 178 | 30 | 3 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.29e-04 | 178 | 30 | 3 | f332c7a96844abecf05ca057480fbea9296688a2 | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.32e-04 | 179 | 30 | 3 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.32e-04 | 179 | 30 | 3 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-04 | 179 | 30 | 3 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.36e-04 | 180 | 30 | 3 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | mild_COVID-19_(asymptomatic)-cDC|World / disease group, cell group and cell class (v2) | 2.36e-04 | 180 | 30 | 3 | 68d1c867734fb2977b01ac686b20bf602f9a6b72 | |
| ToppCell | AT1_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 2.36e-04 | 180 | 30 | 3 | e1964002681f80d8d62406b6ee52a01e1829ccf2 | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.40e-04 | 181 | 30 | 3 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_GGT8P|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-04 | 181 | 30 | 3 | 9842537f9a607d8557c43790008d175edab1f32c | |
| ToppCell | AT1-AT2_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 2.40e-04 | 181 | 30 | 3 | ca23ce4f2c7b684d8ddd0e8619b3b696023d75e3 | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.40e-04 | 181 | 30 | 3 | 9cd5e5c285c2b628db9d59709af053defd7c0aff | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.44e-04 | 182 | 30 | 3 | a95956ce4adccb34cc0c47ebfa1878ce4617904e | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.44e-04 | 182 | 30 | 3 | cc79e0cc21e2fdc4ef77f052818d27b9f707aec1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.44e-04 | 182 | 30 | 3 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.44e-04 | 182 | 30 | 3 | 03a5a02acd48f0eb210485348bfe0cd21f486215 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-04 | 183 | 30 | 3 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.48e-04 | 183 | 30 | 3 | 274483009b309289e4cb84beedf6806430db6ff6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-04 | 183 | 30 | 3 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.48e-04 | 183 | 30 | 3 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 184 | 30 | 3 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 184 | 30 | 3 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-04 | 184 | 30 | 3 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 184 | 30 | 3 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.52e-04 | 184 | 30 | 3 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-04 | 184 | 30 | 3 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 2.52e-04 | 184 | 30 | 3 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.52e-04 | 184 | 30 | 3 | ae0a77e3e520a246b17776bb19503519636b02ee | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-04 | 184 | 30 | 3 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.52e-04 | 184 | 30 | 3 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | IIF-Lymphocyte-B-B_memory|IIF / Disease, Lineage and Cell Type | 2.56e-04 | 185 | 30 | 3 | c0eeab45c4ddefe107690a4ba8868fed2962c730 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 185 | 30 | 3 | 742350093d90f96735dc73e3360cdd749bae63fd | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.56e-04 | 185 | 30 | 3 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-04 | 185 | 30 | 3 | 6da9a06e1514d5d5f47359a14637f02539846096 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.56e-04 | 185 | 30 | 3 | 8ed10ba581849c9c4ac4397226be2b62b4b3b900 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.56e-04 | 185 | 30 | 3 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.56e-04 | 185 | 30 | 3 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.56e-04 | 185 | 30 | 3 | 0c247a3f394c42e2a6f67fee3d9cf33096fecd13 | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.56e-04 | 185 | 30 | 3 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-04 | 185 | 30 | 3 | 4a188e2566a75d1b4f3c879a8c241c277c4b451c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-04 | 185 | 30 | 3 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.56e-04 | 185 | 30 | 3 | b8052cebb73f41abe6faf0aa847be7c8ef23ae94 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-04 | 185 | 30 | 3 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 186 | 30 | 3 | 90d53c2597a9f3a2b39afba75adfc54f1ca0a4db | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 186 | 30 | 3 | 2cae34336f184f971f7c8684cc27c23a4e7369ed | |
| ToppCell | COPD-Epithelial-ATI|COPD / Disease state, Lineage and Cell class | 2.60e-04 | 186 | 30 | 3 | df0977f6f48a2d4e11b59971f098b01204242f0f | |
| ToppCell | IPF-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 2.60e-04 | 186 | 30 | 3 | d436ee6cabbde8553ec5e6e55022274090d9f41a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.60e-04 | 186 | 30 | 3 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-04 | 187 | 30 | 3 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.64e-04 | 187 | 30 | 3 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.64e-04 | 187 | 30 | 3 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-04 | 187 | 30 | 3 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-04 | 187 | 30 | 3 | 24c2a3962da364e46e98abeab5f8234376fa26bb | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 2.64e-04 | 187 | 30 | 3 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.64e-04 | 187 | 30 | 3 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| Drug | GK-101 | 1.40e-07 | 36 | 30 | 4 | CID000161853 | |
| Drug | Madecassol | 3.84e-07 | 46 | 30 | 4 | CID000108062 | |
| Drug | d-indobufen | 5.41e-07 | 50 | 30 | 4 | CID000044562 | |
| Drug | Selara | 5.88e-07 | 125 | 30 | 5 | CID000150310 | |
| Drug | ridogrel | 6.34e-07 | 52 | 30 | 4 | CID005362391 | |
| Drug | NSC49633 | 6.86e-07 | 53 | 30 | 4 | CID000023340 | |
| Drug | AC1LAKND | 1.30e-06 | 62 | 30 | 4 | CID000470146 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 2.12e-06 | 162 | 30 | 5 | CID000072363 | |
| Drug | BAPN | 2.24e-06 | 71 | 30 | 4 | CID000001647 | |
| Drug | malotilate | 2.24e-06 | 71 | 30 | 4 | CID000004006 | |
| Drug | AC1NMZ1B | 2.79e-06 | 75 | 30 | 4 | CID005034185 | |
| Drug | strontium ranelate | 3.10e-06 | 77 | 30 | 4 | CID006918182 | |
| Drug | halofuginone lactate | 4.60e-06 | 85 | 30 | 4 | CID000062891 | |
| Drug | 2-hydroxyheptanoic acid | 5.03e-06 | 3 | 30 | 2 | CID002750949 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 5.03e-06 | 3 | 30 | 2 | CID005748312 | |
| Drug | 8N3-cADPR | 5.03e-06 | 3 | 30 | 2 | CID000127713 | |
| Drug | 2-hydroxycarbazole | 5.03e-06 | 3 | 30 | 2 | CID000093551 | |
| Drug | aminodantrolene | 5.03e-06 | 3 | 30 | 2 | CID009570289 | |
| Drug | cis-diammineplatinum(II | 5.03e-06 | 3 | 30 | 2 | CID000159790 | |
| Drug | 4-hydroxyproline | 6.04e-06 | 91 | 30 | 4 | CID000000825 | |
| Drug | AC1NUZ8M | 6.31e-06 | 92 | 30 | 4 | CID000073211 | |
| Drug | 2,4-xylidinothiazoline | 8.18e-06 | 30 | 30 | 3 | CID000099296 | |
| Drug | ticlopidine | 9.89e-06 | 103 | 30 | 4 | CID000005472 | |
| Drug | SC 38249 | 1.01e-05 | 4 | 30 | 2 | CID000134834 | |
| Drug | AC1L1U7A | 1.01e-05 | 4 | 30 | 2 | CID000035682 | |
| Drug | PCB74 | 1.01e-05 | 4 | 30 | 2 | CID000036218 | |
| Drug | 148504-47-6 | 1.01e-05 | 4 | 30 | 2 | CID006444275 | |
| Drug | hydroxylysine | 1.24e-05 | 109 | 30 | 4 | CID000001029 | |
| Drug | AC1L1C2F | 1.28e-05 | 110 | 30 | 4 | CID000001711 | |
| Drug | PPACK | 1.43e-05 | 113 | 30 | 4 | CID003036757 | |
| Drug | AC1L9732 | 1.48e-05 | 114 | 30 | 4 | CID000439300 | |
| Drug | Tranilast sodium | 1.53e-05 | 115 | 30 | 4 | CID000005527 | |
| Drug | AC1NBU2S | 1.64e-05 | 117 | 30 | 4 | CID004473765 | |
| Drug | fensulfothion | 1.67e-05 | 5 | 30 | 2 | CID000008292 | |
| Drug | A 68930 | 1.67e-05 | 5 | 30 | 2 | ctd:C065380 | |
| Drug | cyclophorine | 1.68e-05 | 426 | 30 | 6 | CID000002909 | |
| Drug | AC1O528X | 2.51e-05 | 6 | 30 | 2 | CID006475857 | |
| Drug | NSC114784 | 2.51e-05 | 6 | 30 | 2 | CID000419425 | |
| Drug | vinyl phosphate | 2.51e-05 | 6 | 30 | 2 | CID000135020 | |
| Drug | MBED | 2.51e-05 | 6 | 30 | 2 | CID000129958 | |
| Drug | chloro-m-cresol | 2.51e-05 | 6 | 30 | 2 | CID000012008 | |
| Drug | DMSe | 2.63e-05 | 132 | 30 | 4 | CID000020796 | |
| Drug | 4,4'-dithiodipyridine | 2.82e-05 | 45 | 30 | 3 | CID000075846 | |
| Drug | pirfenidone | 3.13e-05 | 138 | 30 | 4 | CID000040632 | |
| Drug | DL-penicillamine | 3.22e-05 | 139 | 30 | 4 | CID000004727 | |
| Drug | PCR 4099 | 3.22e-05 | 139 | 30 | 4 | CID000002806 | |
| Drug | Azumoleno | 3.51e-05 | 7 | 30 | 2 | CID000056259 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 3.51e-05 | 7 | 30 | 2 | CID009547999 | |
| Drug | Br2BAPTA | 3.51e-05 | 7 | 30 | 2 | CID003081001 | |
| Drug | AC1L9KQO | 3.65e-05 | 49 | 30 | 3 | CID000447335 | |
| Drug | candesartan cilexetil | 3.80e-05 | 145 | 30 | 4 | CID000002540 | |
| Drug | khellin | 7.23e-05 | 171 | 30 | 4 | CID000003828 | |
| Drug | PCB 95 | 7.50e-05 | 10 | 30 | 2 | CID000038012 | |
| Drug | lercanidipine | 7.77e-05 | 63 | 30 | 3 | CID000065866 | |
| Drug | AC1L1DD6 | 8.63e-05 | 179 | 30 | 4 | CID000002299 | |
| Drug | R 478 | 9.16e-05 | 11 | 30 | 2 | CID000084223 | |
| Drug | 2,3,6,2',3',6'-hexachlorobiphenyl | 9.16e-05 | 11 | 30 | 2 | ctd:C010498 | |
| Drug | 8-amino-cADPR | 9.16e-05 | 11 | 30 | 2 | CID003081323 | |
| Drug | PCB 66 | 9.16e-05 | 11 | 30 | 2 | CID000036185 | |
| Drug | tectoridin | 9.16e-05 | 11 | 30 | 2 | CID005281810 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 1.06e-04 | 189 | 30 | 4 | CID000001413 | |
| Drug | foscarnet | 1.09e-04 | 190 | 30 | 4 | CID000003414 | |
| Drug | Ryanodine | 1.10e-04 | 12 | 30 | 2 | ctd:D012433 | |
| Drug | Sulfapyridine [144-83-2]; Up 200; 16uM; HL60; HT_HG-U133A | 1.20e-04 | 195 | 30 | 4 | 2538_UP | |
| Drug | Gabazine [105538-73-6]; Up 200; 10.8uM; PC3; HT_HG-U133A | 1.27e-04 | 198 | 30 | 4 | 4236_UP | |
| Drug | pyrraline | 1.74e-04 | 15 | 30 | 2 | CID000122228 | |
| Drug | FPL 64176 | 1.74e-04 | 15 | 30 | 2 | CID000003423 | |
| Drug | Gvapspat amide | 1.74e-04 | 15 | 30 | 2 | CID000125015 | |
| Drug | LMWH | 1.95e-04 | 663 | 30 | 6 | CID000000772 | |
| Drug | NOC 18 | 1.99e-04 | 16 | 30 | 2 | ctd:C093285 | |
| Drug | kazinol B | 2.25e-04 | 17 | 30 | 2 | CID000480869 | |
| Drug | AC1Q6PCP | 2.26e-04 | 230 | 30 | 4 | CID000005267 | |
| Drug | methylcoumarin | 2.53e-04 | 18 | 30 | 2 | CID000007092 | |
| Drug | isotetrandrine | 2.80e-04 | 97 | 30 | 3 | CID000005422 | |
| Drug | AC1L380G | 2.83e-04 | 19 | 30 | 2 | CID000084698 | |
| Drug | AC1MW7VF | 2.83e-04 | 19 | 30 | 2 | CID000414699 | |
| Drug | SK&F 82958 | 2.83e-04 | 19 | 30 | 2 | ctd:C071262 | |
| Drug | prostacyclin sodium salt | 3.11e-04 | 250 | 30 | 4 | CID000000159 | |
| Drug | Baclofen | 3.14e-04 | 20 | 30 | 2 | ctd:D001418 | |
| Drug | 351A | 3.14e-04 | 20 | 30 | 2 | CID000122144 | |
| Drug | hygronium | 3.14e-04 | 20 | 30 | 2 | CID000071512 | |
| Drug | 2,2',3,5',6-pentachlorobiphenyl | 3.14e-04 | 20 | 30 | 2 | ctd:C032904 | |
| Drug | indo-1/AM | 3.47e-04 | 21 | 30 | 2 | CID000123918 | |
| Drug | tectorigenin | 3.47e-04 | 21 | 30 | 2 | CID005281811 | |
| Drug | loperamide | 3.53e-04 | 105 | 30 | 3 | CID000003954 | |
| Drug | hyaluronan | 3.76e-04 | 263 | 30 | 4 | CID000024759 | |
| Drug | AC1L1KON | 4.61e-04 | 115 | 30 | 3 | CID000005589 | |
| Drug | T0702 | 4.94e-04 | 25 | 30 | 2 | CID000005908 | |
| Drug | alamos | 4.94e-04 | 25 | 30 | 2 | CID000079914 | |
| Drug | silibinin | 5.10e-04 | 285 | 30 | 4 | CID000005213 | |
| Drug | LS-63783 | 5.47e-04 | 804 | 30 | 6 | CID000000231 | |
| Drug | S-nitrosoacetylcysteine | 6.67e-04 | 29 | 30 | 2 | CID000122058 | |
| Drug | excavatolide B | 6.67e-04 | 29 | 30 | 2 | ctd:C574336 | |
| Drug | Bicuculline | 6.67e-04 | 29 | 30 | 2 | ctd:D001640 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | 6.82e-04 | 308 | 30 | 4 | CID000001915 | |
| Drug | LOPAC | 7.14e-04 | 30 | 30 | 2 | CID000062696 | |
| Drug | KT 5823 | 7.14e-04 | 30 | 30 | 2 | ctd:C073601 | |
| Drug | (2s,5s)-5-Carboxymethylproline | 7.33e-04 | 314 | 30 | 4 | CID000447989 | |
| Drug | M-HN | 7.62e-04 | 31 | 30 | 2 | CID000015450 | |
| Drug | M3/M4 | 8.12e-04 | 32 | 30 | 2 | CID000486507 | |
| Disease | Hematuria, Benign Familial | 3.06e-09 | 4 | 28 | 3 | C0241908 | |
| Disease | Alport Syndrome, X-Linked | 7.64e-09 | 5 | 28 | 3 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 7.64e-09 | 5 | 28 | 3 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 7.64e-09 | 5 | 28 | 3 | C1567744 | |
| Disease | hypertensive nephropathy | 1.53e-08 | 6 | 28 | 3 | C0848548 | |
| Disease | collagen disease (implicated_via_orthology) | 1.67e-07 | 12 | 28 | 3 | DOID:854 (implicated_via_orthology) | |
| Disease | ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE | 8.68e-07 | 2 | 28 | 2 | C4746745 | |
| Disease | benign familial hematuria (is_implicated_in) | 8.68e-07 | 2 | 28 | 2 | DOID:0111365 (is_implicated_in) | |
| Disease | autosomal recessive Alport syndrome (is_implicated_in) | 8.68e-07 | 2 | 28 | 2 | DOID:0110033 (is_implicated_in) | |
| Disease | Alport syndrome, recessive type | 8.68e-07 | 2 | 28 | 2 | C2931254 | |
| Disease | Alport syndrome, dominant type | 8.68e-07 | 2 | 28 | 2 | C2931253 | |
| Disease | Thin basement membrane disease | 8.68e-07 | 2 | 28 | 2 | C0403440 | |
| Disease | Benign familial hematuria | 8.68e-07 | 2 | 28 | 2 | cv:C0241908 | |
| Disease | Renal glomerular disease | 1.34e-06 | 23 | 28 | 3 | C0268731 | |
| Disease | Glomerulopathy Assessment | 1.34e-06 | 23 | 28 | 3 | C4521256 | |
| Disease | Alport syndrome | 2.60e-06 | 3 | 28 | 2 | cv:C1567741 | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 2.60e-06 | 3 | 28 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 2.60e-06 | 3 | 28 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | autosomal recessive Alport syndrome (implicated_via_orthology) | 2.60e-06 | 3 | 28 | 2 | DOID:0110033 (implicated_via_orthology) | |
| Disease | Collagen IV-related nephropathies | 2.60e-06 | 3 | 28 | 2 | cv:CN076135 | |
| Disease | Alport Syndrome | 5.20e-06 | 4 | 28 | 2 | C1567741 | |
| Disease | myopathy (implicated_via_orthology) | 1.29e-05 | 48 | 28 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | macula measurement | 2.96e-05 | 189 | 28 | 4 | EFO_0008375 | |
| Disease | Nephrotic Syndrome | 3.00e-04 | 27 | 28 | 2 | C0027726 | |
| Disease | Hereditary hearing loss and deafness | 3.55e-04 | 146 | 28 | 3 | cv:C0236038 | |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 3.72e-04 | 30 | 28 | 2 | C1868672 | |
| Disease | diastolic blood pressure, systolic blood pressure | 3.79e-04 | 670 | 28 | 5 | EFO_0006335, EFO_0006336 | |
| Disease | retinal detachment, retinal break | 5.07e-04 | 35 | 28 | 2 | EFO_0005773, EFO_0010698 | |
| Disease | end stage renal disease (is_implicated_in) | 6.96e-04 | 41 | 28 | 2 | DOID:783 (is_implicated_in) | |
| Disease | Acute Promyelocytic Leukemia | 8.76e-04 | 46 | 28 | 2 | C0023487 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SFPFHGSRPAGLPGL | 666 | Q8NDL9 | |
| GAPGFPGISGHPGKK | 831 | Q14031 | |
| LIGPKGFPGFPGLHG | 1161 | Q14031 | |
| ARGLKGPGTPAFPHY | 66 | Q15744 | |
| IVFRKGPPGDHGLPG | 441 | Q01955 | |
| DPAFGHLGPPGKRGL | 761 | P53420 | |
| GQHGLPGFPGLKGVP | 521 | P08572 | |
| PQAHPGLGGGPKSGF | 1571 | Q5TGY3 | |
| LFPGHLAPKPGLPYG | 691 | Q6W2J9 | |
| GFPGTPGLPGVKGHR | 276 | P02458 | |
| PGLPGVKGHRGYPGL | 281 | P02458 | |
| KGRHFGVHPAPGFPG | 6 | Q5VVQ6 | |
| PSPRLVLHFGGGGFL | 161 | Q969S2 | |
| PPAHFQPGKGLFGAG | 156 | P58012 | |
| PGGSSSFLHKPFPGG | 861 | Q8TDM6 | |
| HLLPGRAKGPGLFFF | 141 | Q9NP85 | |
| PGARGGLGLPEHFLP | 946 | Q9Y3Q4 | |
| FPGLHSFAPDKPGGI | 71 | Q15165 | |
| LRFGGTPIHFPGGRP | 431 | P51841 | |
| RGGPGGGFRPFVPHI | 16 | Q12905 | |
| GPHVSLNVFFGKPGP | 921 | Q9UHN6 | |
| GRKGHKGYPGPAGHP | 706 | Q8IZC6 | |
| AAPSPHGRKGPGLFG | 166 | Q9NT22 | |
| GLPGVPPFLLHRGGG | 226 | O95865 | |
| LLGGRHGEFKFLPPP | 791 | P21817 | |
| GRHGEFKFLPPPGYA | 806 | Q92736 | |
| LVPGLPGGGSAKFPF | 21 | P82914 | |
| HVALPQGKGFFPPRG | 161 | B1ATL7 | |
| SALRPHFGPFPGVLG | 26 | Q8IYB8 | |
| GPGPTVKPSGHLFFR | 296 | Q5VW32 | |
| GPFRLGGHGPSFPLK | 181 | P13010 | |
| GINSHFGPGPTLGKP | 2561 | O14686 |